Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel
Titel:
Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel
Auteur:
Sarantopoulos, John Mita, Alain C. Wade, James L. Morris, John C. Rixe, Olivier Mita, Monica M. Dedieu, Jean-François Wack, Claudine Kassalow, Laurent Craig Lockhart, A.